The Clorox Company (CLX)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $13.35B
Last updated: Nov 17, 2026 at 4:42 PM ET
The Clorox Company (CLX) Statistics
The Clorox Company (CLX) has a market cap of $13.35B and an enterprise value of $18.32B. Its dividend yield is 4.69%. Its trailing P/E of 17.1x is below its 10-year median of 24.5x.
Total Valuation
Enterprise value is 37.27% above the market cap, as debt exceeds cash.
| Market Cap | $13.35B |
|---|---|
| Enterprise Value | $18.32B |
| Latest price (Nov 17, 2026) | $106.67 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Oct 28, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Last Ex-Dividend Date | Oct 28, 2026 |
| Last Payment Date | Nov 13, 2026 |
| Fiscal Year End | June |
Valuation Ratios
The price to sales ratio is 1.8x. Its year-end P/E ranged from 15.4x to 39.3x from 2016 to 2025.
| P/E Ratio | 17.1x |
|---|---|
| Forward P/E | 18.4x |
| P/S Ratio | 1.8x |
| Forward P/S | 1.7x |
| P/FCF Ratio | 28.6x |
| P/OCF Ratio | 20.2x |
| PEG Ratio | 1.8 |
Enterprise Valuation
Counting debt and cash, the company is valued at 13.9x EBITDA and 39.6x free cash flow.
| EV / Earnings | 26.5x |
|---|---|
| EV / Sales | 2.5x |
| EV / EBITDA | 13.9x |
| EV / EBIT | 17.4x |
| EV / FCF | 39.6x |
Price Statistics
The stock is up 4.05% over 52 weeks and trades 20.44% above its 50-day average.
| Beta (1Y) | 0.37 |
|---|---|
| 52-Week Change | +4.05% |
| 1-Month Change | +26.46% |
| 3-Month Change | +0.28% |
| 6-Month Change | +16.59% |
| 5-Year Change | -46.02% |
| 10-Year Change | -26.68% |
| Total Return (1Y) | +8.91% |
| Total Return (3Y CAGR) | -6.34% |
| Total Return (5Y CAGR) | -5.97% |
| Return vs SPY (1Y) | -3.83% |
| Max Drawdown (1Y) | -36.86% |
| Max Drawdown (3Y) | -51.54% |
| Sharpe Ratio (1Y) | 0.23 |
| Correlation with SPY (1Y) | 0.16 |
| 50-Day Average | $88.57 |
| 200-Day Average | $97.67 |
| 52-Week Range | $77.99 to $124.03 |
| RSI (14 Days) | 72.1 |
| Average Volume (20 Days) | 3.69M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.65x current liabilities.
| Current Ratio | 0.65x |
|---|---|
| Quick Ratio | 0.39x |
| Debt / EBITDA | 4.01x |
| Debt / FCF | 11.39x |
| Interest Coverage | 6.60x |
Returns and Efficiency
Return on invested capital is 15.93% over the last 12 months, against a 5-year average of 16.61%.
| Return on Assets (ROA) | 8.84% |
|---|---|
| Return on Invested Capital (ROIC) | 15.93% |
| Return on Capital Employed (ROCE) | 21.53% |
| ROE (5Y Average) | 234.28% |
| ROA (5Y Average) | 7.59% |
| ROIC (5Y Average) | 16.61% |
| Asset Turnover | 1.08x |
| Inventory Turnover | 5.39x |
| Receivables Turnover | 9.37x |
| Cash Conversion Cycle | -37 days |
Taxes
Income tax took 22.33% of pretax income over the last 12 months.
| Income Tax (TTM) | $199.00M |
|---|---|
| Effective Tax Rate | 22.33% |
Scores
CLX has an Altman Z-Score of 2.26, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.26 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $7.20B over the last 12 months is up 6.28% from the 12 months before.
| Revenue | $7.20B |
|---|---|
| Revenue Growth (YoY) | +6.28% |
| Gross Profit | $3.02B |
| Operating Income | $1.05B |
| Pretax Income | $891.00M |
| Net Income | $692.00M |
| EBITDA | $1.29B |
| EBIT | $1.05B |
| Reported EPS (TTM) | $6.24 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $184.00M |
|---|---|
| Total Debt | $5.16B |
| Net Debt | $4.97B |
| Net Debt Per Share | $40.90 |
| Working Capital | -$1.02B |
| Shareholder Equity | -$39.00M |
| Tangible Book Value | -$3.56B |
| Total Assets | $7.83B |
| Total Liabilities | $7.71B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $209.00M of capital spending, operating cash flow left $453.00M of free cash flow.
| Operating Cash Flow | $662.00M |
|---|---|
| Capital Expenditures | $209.00M |
| Free Cash Flow | $453.00M |
| FCF Per Share | $3.75 |
| Depreciation and Amortization | $237.00M |
| Dividends Paid | $618.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 14.58%, against a 5-year average of 10.90%.
| Gross Margin | 41.94% |
|---|---|
| Operating Margin | 14.58% |
| Pretax Margin | 12.38% |
| Net Margin | 9.62% |
| EBITDA Margin | 17.88% |
| EBIT Margin | 14.59% |
| FCF Margin | 6.30% |
| Gross Margin (5Y Average) | 41.14% |
| Operating Margin (5Y Average) | 10.90% |
| Net Margin (5Y Average) | 6.69% |
Growth
Revenue fell 3.11% a year over 3 years, and EPS grew 2.86% a year.
| Revenue Growth (3Y CAGR) | -3.11% |
|---|---|
| Revenue Growth (5Y CAGR) | -1.75% |
| EPS Growth (3Y CAGR) | +2.86% |
| EPS Growth (5Y CAGR) | -6.66% |
| FCF Growth (3Y CAGR) | -24.20% |
| FCF Growth (5Y CAGR) | -15.59% |
| Operating Income Growth (3Y CAGR) | +30.80% |
Dividends and Yields
CLX pays out 87.52% of earnings as dividends.
| Dividend Per Share (Annual) | $5.00 |
|---|---|
| Dividend Yield | 4.69% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +1.68% |
| Dividend Growth (5Y CAGR) | +2.54% |
| Payout Ratio | 87.52% |
| FCF Payout Ratio | 136.42% |
| Earnings Yield | 5.85% |
| FCF Yield | 3.49% |
| Buyback Yield | 1.26% |
| Shareholder Yield | 6.02% |
Stock Splits
The last split was a 2-for-1 forward split on Aug 24, 1999.
| Last Split Date | Aug 24, 1999 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 11 similar companies, CLX has the 9th highest P/E and the 7th highest P/S.
P/E RatioPeer median 24.9x
P/S RatioPeer median 2.2x
ROICPeer median 15.02%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +3.05%
Dividend YieldPeer median 1.22%
| P/E Ratio | 17.1x vs 24.9x median |
|---|---|
| P/S Ratio | 1.8x vs 2.2x median |
| ROIC | 15.93% vs 15.02% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.28% vs +3.05% median |
| Dividend Yield | 4.69% vs 1.22% median |
Analyst Forecast
Consensus estimates put revenue growth at 7.79% and EPS growth at 5.52% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +7.79% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +5.52% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CLX
What is CLX's market cap?
The Clorox Company has a market cap of $13.35B. Its enterprise value, which adds debt and subtracts cash, is $18.32B.
What is CLX's P/E ratio?
The Clorox Company has a trailing P/E ratio of 17.1x and a forward P/E of 18.4x.
How many shares of CLX are outstanding?
The Clorox Company has 121.62M shares outstanding. The count is down 0.82% from a year earlier.
Does CLX pay a dividend?
Yes. The Clorox Company pays $5.00 a share a year, a dividend yield of 4.69%.
How much debt does CLX have?
The Clorox Company has $5.16B of total debt and $184.00M of cash and equivalents, a net debt position of $4.97B.
CLX pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors